{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:33:46Z","timestamp":1792960426216,"version":"4.5.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003562","name":"Ministry of Environment","doi-asserted-by":"publisher","award":["RS-2022-KE002067"],"award-info":[{"award-number":["RS-2022-KE002067"]}],"id":[{"id":"10.13039\/501100003562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hazardous Materials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jhazmat.2026.143711","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:22:42Z","timestamp":1790097762000},"page":"143711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Back-transformation and dual-type metabolites associated with pharmaceutical negative removal and residual ecological risks in biological treatment"],"prefix":"10.1016","volume":"517","author":[{"given":"Heewon","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-6779","authenticated-orcid":false,"given":"Daeho","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-2881","authenticated-orcid":false,"given":"Junho","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhazmat.2026.143711_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.127284","article-title":"Abundance, fate, and effects of pharmaceuticals and personal care products in aquatic environments","volume":"424","author":"Adeleye","year":"2022","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2026.143711_bib2","doi-asserted-by":"crossref","first-page":"9828","DOI":"10.1021\/acs.est.4c00968","article-title":"How wastewater reflects human metabolism\u2500suspect screening of pharmaceutical metabolites in wastewater influent","volume":"58","author":"Meyer","year":"2024","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2025.123229","article-title":"Microbial metabolic enzymes, pathways and microbial hosts for co-metabolic degradation of organic micropollutants in wastewater","volume":"276","author":"Lyu","year":"2025","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.136811","article-title":"Profiling trace organic chemical biotransformation genes, enzymes and associated bacteria in microbial model communities","volume":"485","author":"Cao","year":"2025","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2026.143711_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.watres.2014.09.033","article-title":"Impact of in-sewer transformation on 43 pharmaceuticals in a pressurized sewer under anaerobic conditions","volume":"68","author":"Jelic","year":"2015","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2025.123983","article-title":"Comparing the abatement of pharmaceuticals and their human metabolites in wastewater treatment plants \u2013 Insights from biological and advanced treatment stages","volume":"285","author":"Meyer","year":"2025","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.chemosphere.2017.01.101","article-title":"The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental waters","volume":"174","author":"Archer","year":"2017","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jhazmat.2012.04.078","article-title":"De-conjugation behavior of conjugated estrogens in the raw sewage, activated sludge and river water","volume":"227\u2013228","author":"Kumar","year":"2012","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2026.143711_bib9","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1021\/acs.est.5c17466","article-title":"Understanding the Role of Deconjugation of Phase II Metabolites in Wastewater: Implications for Wastewater-Based Epidemiology","volume":"60","author":"Elliss","year":"2026","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1021\/acsestwater.1c00025","article-title":"Methodological Advances to Study Contaminant Biotransformation: New Prospects for Understanding and Reducing Environmental Persistence?","volume":"1","author":"Fenner","year":"2021","journal-title":"ACS ES&T Water"},{"key":"10.1016\/j.jhazmat.2026.143711_bib11","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1021\/es100970m","article-title":"High-Throughput Identification of Microbial Transformation Products of Organic Micropollutants","volume":"44","author":"Helbling","year":"2010","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib12","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0569","article-title":"Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems","volume":"369","author":"Arnold","year":"2014","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"10.1016\/j.jhazmat.2026.143711_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2023.119724","article-title":"Occurrence of quantifiable and semi-quantifiable poly- and perfluoroalkyl substances in united states wastewater treatment plants","volume":"233","author":"Schaefer","year":"2023","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib14","doi-asserted-by":"crossref","first-page":"7435","DOI":"10.1007\/s00216-022-04084-6","article-title":"A novel workflow for semi-quantification of emerging contaminants in environmental samples analyzed by LC-HRMS","volume":"414","author":"Aalizadeh","year":"2022","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jhazmat.2026.143711_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.869332","article-title":"Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems","volume":"13","author":"Ort\u00fazar","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.174715","article-title":"Discovering transformation products of pharmaceuticals in domestic wastewaters and receiving rivers by using non-target screening and machine learning approaches","volume":"948","author":"Han","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib17","unstructured":"ECHA, Guidance on the Application of the CLP Criteria, Parts 4 and 5 Guidance on the Application of the CLP Criteria Part 4: Environmental hazards and Part 5: Additional Hazards Guidance to Regulation (EC) No 1272\/2008 on classification, labelling and packaging (CLP) of substances and mixtures 2024. https:\/\/doi.org\/10.2823\/4895485."},{"key":"10.1016\/j.jhazmat.2026.143711_bib18","unstructured":"ECHA. Classification criteria for PBTvPvB and PMTvPvM substances_ECHA 2023."},{"key":"10.1016\/j.jhazmat.2026.143711_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2024.141402","article-title":"Profiling emerging micropollutants in urban stormwater runoff using suspect and non-target screening via high-resolution mass spectrometry","volume":"352","author":"Kang","year":"2024","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib20","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1021\/es5002105","article-title":"Identifying small molecules via high resolution mass spectrometry: communicating confidence","volume":"48","author":"Schymanski","year":"2014","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib21","doi-asserted-by":"crossref","first-page":"13219","DOI":"10.1021\/acs.analchem.7b03037","article-title":"LC-HRMS data processing strategy for reliable sample comparison exemplified by the assessment of water treatment processes","volume":"89","author":"Bader","year":"2017","journal-title":"Anal Chem"},{"key":"10.1016\/j.jhazmat.2026.143711_bib22","doi-asserted-by":"crossref","first-page":"17439","DOI":"10.1021\/acs.est.3c05008","article-title":"Suspect and nontarget screening reveal the underestimated risks of antibiotic transformation products in wastewater treatment plant effluents","volume":"57","author":"Hu","year":"2023","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib23","unstructured":"NORMAN Ecotoxicology Database \u2014 Lowest PNECs n.d. https:\/\/www.norman-network.com\/nds\/ecotox\/lowestPnecsIndex.php (accessed November 6, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib24","unstructured":"Batch Process R Guidance on information requirements and chemical safety assessment Chapter R.10: Characterisation of dose [concentration]-response for environment Guidance for the implementation of REACH. 2008."},{"key":"10.1016\/j.jhazmat.2026.143711_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-13-S2-S11","article-title":"Fold change and p-value cutoffs significantly alter microarray interpretations","volume":"13","author":"Dalman","year":"2012","journal-title":"BMC Bioinforma"},{"key":"10.1016\/j.jhazmat.2026.143711_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115024","article-title":"Prioritization of pharmaceuticals and personal care products in the surface waters of Korea: application of an optimized risk-based methods","volume":"259","author":"Kim","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.jhazmat.2026.143711_bib27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.scitotenv.2015.06.067","article-title":"Occurrence and removal of frequently prescribed pharmaceuticals and corresponding metabolites in wastewater of a sewage treatment plant","volume":"532","author":"Gurke","year":"2015","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.149860","article-title":"Assessment of a wide array of organic micropollutants of emerging concern in wastewater treatment plants in Greece: Occurrence, removals, mass loading and potential risks","volume":"802","author":"Ofrydopoulou","year":"2022","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.scitotenv.2018.11.433","article-title":"Environmental fate of pharmaceutical compounds and antimicrobial-resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan","volume":"657","author":"Azuma","year":"2019","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib30","unstructured":"Health Insurance Review & Assessment Service (HIRA) n.d. https:\/\/opendata.hira.or.kr\/ (accessed November 6, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12937-022-00774-0","article-title":"Prevalence of caffeine consumers, daily caffeine consumption, and factors associated with caffeine use among active duty United States military personnel","volume":"21","author":"Knapik","year":"2022","journal-title":"Nutr J"},{"key":"10.1016\/j.jhazmat.2026.143711_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.132629","volume":"288","author":"Choi","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib33","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/molecules25071639","article-title":"A Survey of the Presence of Pharmaceutical Residues in Wastewaters. Evaluation of Their Removal using Conventional and Natural Treatment Procedures","volume":"25","author":"Guedes-Alonso","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jhazmat.2026.143711_bib34","article-title":"Inflow and outflow loads of 484 daily-use chemicals in wastewater treatment plants across Japan","volume":"1","author":"Kadokami","year":"2021","journal-title":"Environ Monit Contam Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.emcon.2016.09.001","article-title":"Biodegradation of bezafibrate by the activated sludge under aerobic condition: Effect of initial concentration, temperature and pH","volume":"2","author":"Sui","year":"2016","journal-title":"Emerg Contam"},{"key":"10.1016\/j.jhazmat.2026.143711_bib36","first-page":"849","article-title":"Solar Photocatalytic Membranes: An Experimental and Artificial Neural Network Modeling Approach for Niflumic Acid Degradation","volume":"12","author":"Aoudjit","year":"2022","journal-title":"Membr (Basel)"},{"key":"10.1016\/j.jhazmat.2026.143711_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2021.132393","article-title":"UV and (V)UV irradiation of sitagliptin in ultrapure water and WWTP effluent: Kinetics, transformation products and degradation pathway","volume":"288","author":"Krakk\u00f3","year":"2022","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib38","first-page":"936","article-title":"Differential biotransformation of micropollutants in conventional activated sludge and up-flow anaerobic sludge blanket processes","volume":"10","author":"Martin","year":"2024","journal-title":"Environ Sci (Camb"},{"key":"10.1016\/j.jhazmat.2026.143711_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.biortech.2022.127054","article-title":"Critical review on negative emerging contaminant removal efficiency of wastewater treatment systems: Concept, consistency and consequences","volume":"352","author":"Kumar","year":"2022","journal-title":"Bioresour Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhazmat.2016.08.022","article-title":"Occurrence and fate of amisulpride, sulpiride, and lamotrigine in municipal wastewater treatment plants with biological treatment and ozonation","volume":"320","author":"Bollmann","year":"2016","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2026.143711_bib41","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199733030-00003","article-title":"Clinical Pharmacokinetics of Diclofenac","volume":"33","author":"Davies","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhazmat.2026.143711_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2020.124984","article-title":"Retrospective mass spectrometric analysis of wastewater-fed mesocosms to assess the degradation of drugs and their human metabolites","volume":"408","author":"Sabater-Liesa","year":"2021","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2026.143711_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2025.121752","article-title":"Occurrence and removal of pharmaceuticals in hospital wastewater and the contribution to wastewater treatment plants","volume":"279","author":"Tao","year":"2025","journal-title":"Environ Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.07.371","article-title":"Comprehensive investigation of a wide range of pharmaceuticals and personal care products in urban and hospital wastewaters in Greece","volume":"694","author":"Papageorgiou","year":"2019","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10661-024-13515-z","article-title":"Removal efficiencies and environmental risk assessment of selected pharmaceuticals and metabolites at a wastewater treatment plant in Pietermaritzburg, South Africa","volume":"197","author":"Inarmal","year":"2024","journal-title":"Environ Monit Assess"},{"key":"10.1016\/j.jhazmat.2026.143711_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2024.122431","article-title":"Adaptation towards catabolic biodegradation of trace organic contaminants in activated sludge","volume":"266","author":"Seller-Brison","year":"2024","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ecoenv.2018.01.040","article-title":"Biodegradation of Diclofenac by the bacterial strain Labrys portucalensis F11","volume":"152","author":"Moreira","year":"2018","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.jhazmat.2026.143711_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2022.119352","article-title":"Sartan blood pressure regulators in classical and biofilm wastewater treatment \u2013 Concentrations and metabolism","volume":"229","author":"Li","year":"2023","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib49","author":"Evans","year":"2025","journal-title":"Caffeine"},{"key":"10.1016\/j.jhazmat.2026.143711_bib50","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/15563650.2016.1146740","article-title":"Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults","volume":"54","author":"White","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib51","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.2174\/092986709789057635","article-title":"Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development","volume":"16","author":"Zhou","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jhazmat.2026.143711_bib52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2125.2005.02446.x","article-title":"S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen","volume":"60","author":"Bowalgaha","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602530701836662","article-title":"Cytochromes P450: A Structure-Based Summary of Biotransformations Using Representative Substrates","volume":"40","author":"Brown","year":"2008","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhazmat.2026.143711_bib54","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1081\/DMR-100101942","article-title":"THE ROLE OF CYP2B6 IN HUMAN XENOBIOTIC METABOLISM*","volume":"31","author":"EKINS","year":"1999","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhazmat.2026.143711_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1081\/DMR-120001392","article-title":"Summary of information on human CYP enzymes: human P450 metabolism data","volume":"34","author":"Rendic","year":"2002","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhazmat.2026.143711_bib56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","article-title":"Clinical Pharmacokinetics of Losartan","volume":"44","author":"Sica","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhazmat.2026.143711_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2021.109435","article-title":"Degradation mechanism of losartan in aqueous solutions under the effect of gamma radiation","volume":"184","author":"Zaouak","year":"2021","journal-title":"Radiat Phys Chem"},{"key":"10.1016\/j.jhazmat.2026.143711_bib58","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0731-7085(02)00385-0","article-title":"Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products","volume":"30","author":"Hertzog","year":"2002","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jhazmat.2026.143711_bib59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.comptc.2012.11.018","article-title":"Mechanistic insights into the bioactivation of phenacetin to reactive metabolites: A DFT study","volume":"1007","author":"Taxak","year":"2013","journal-title":"Comput Theor Chem"},{"key":"10.1016\/j.jhazmat.2026.143711_bib60","unstructured":"[Phenacetin]Viewing Biotransformations for CCOC1=CC5C(C5C1)NC(=O)C n.d. https:\/\/biotransformer.ca\/queries\/174489\/status?query_smiles= (accessed November 7, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib61","first-page":"1029","article-title":"Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model","volume":"29","author":"Hutzler","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhazmat.2026.143711_bib62","first-page":"189","article-title":"A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs","volume":"19","author":"Leemann","year":"1993","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib63","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/rcm.1631","article-title":"The detection of piroxicam, tenoxicam and their metabolites in equine urine by electrospray ionisation ion trap mass spectrometry","volume":"18","author":"McKinney","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jhazmat.2026.143711_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.scitotenv.2012.08.038","article-title":"Ecotoxicity evaluation and removal of sulfonamides and their acetylated metabolites during conventional wastewater treatment","volume":"437","author":"Garc\u00eda-Gal\u00e1n","year":"2012","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/chemosensors9100273","article-title":"Comprehensive Characterization of 76 Pharmaceuticals and Metabolites in Wastewater by LC-MS\/MS","volume":"9","author":"G\u00f3mez-Canela","year":"2021","journal-title":"Chemosensors"},{"key":"10.1016\/j.jhazmat.2026.143711_bib66","unstructured":"FDA. DIOVAN\u00ae (valsartan) tablets, for oral use. 2015."},{"key":"10.1016\/j.jhazmat.2026.143711_bib67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.chroma.2008.09.060","article-title":"Identification and structural characterization of biodegradation products of atenolol and glibenclamide by liquid chromatography coupled to hybrid quadrupole time-of-flight and quadrupole ion trap mass spectrometry","volume":"1210","author":"Radjenovi\u0107","year":"2008","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jhazmat.2026.143711_bib68","unstructured":"EAWAG-BBD: Pathway Prediction Results. n.d."},{"key":"10.1016\/j.jhazmat.2026.143711_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312652121","article-title":"Dinickel enzyme evolved to metabolize the pharmaceutical metformin and its implications for wastewater and human microbiomes","volume":"121","author":"Tassoulas","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jhazmat.2026.143711_bib70","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1038\/s41467-024-50409-7","article-title":"Discovery of a Ni2+-dependent heterohexameric metformin hydrolase","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhazmat.2026.143711_bib71","doi-asserted-by":"crossref","first-page":"8045","DOI":"10.1038\/s41467-024-51752-5","article-title":"Metformin hydrolase is a recently evolved nickel-dependent heteromeric ureohydrolase","volume":"15","author":"Sinn","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhazmat.2026.143711_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2019.109414","article-title":"Biodegradation of metformin and its transformation product, guanylurea, by natural and exposed microbial communities","volume":"182","author":"Poursat","year":"2019","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.jhazmat.2026.143711_bib73","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.watres.2014.12.010","article-title":"Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters","volume":"70","author":"Kosma","year":"2015","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib74","article-title":"Sartans: What they are for, how they degrade, where they are found and how they transform","volume":"20","author":"Ladhari","year":"2021","journal-title":"Sustain Chem Pharm"},{"key":"10.1016\/j.jhazmat.2026.143711_bib75","unstructured":"[Sitagliptin]Viewing Biotransformations for C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C5C3F)F)F)N n.d. https:\/\/biotransformer.ca\/queries\/174849\/status?query_smiles= (accessed November 7, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2019.115034","article-title":"Biological transformation of fexofenadine and sitagliptin by carrier-attached biomass and suspended sludge from a hybrid moving bed biofilm reactor","volume":"167","author":"Henning","year":"2019","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib77","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1021\/acs.est.5b05186","article-title":"Systematic Exploration of Biotransformation Reactions of Amine-Containing Micropollutants in Activated Sludge","volume":"50","author":"Gulde","year":"2016","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib78","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.watres.2014.03.022","article-title":"Carbamazepine and its metabolites in wastewater: Analytical pitfalls and occurrence in Germany and Portugal","volume":"57","author":"Bahlmann","year":"2014","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s002130050524","article-title":"An active metabolite of carbamazepine, carbamazepine-10,11-epoxide, inhibits ion channel-mediated catecholamine secretion in cultured bovine adrenal medullary cells","volume":"135","author":"Yoshimura","year":"1998","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1016\/j.jhazmat.2026.143711_bib80","unstructured":"Carbamazepine Pathway, Pharmacokinetics n.d. https:\/\/www.clinpgx.org\/pathway\/PA165817070 (accessed November 6, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib81","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00244-008-9202-x","article-title":"Presence and Fate of Carbamazepine, Oxcarbazepine, and Seven of Their Metabolites at Wastewater Treatment Plants","volume":"56","author":"Leclercq","year":"2009","journal-title":"Arch Environ Contam Toxicol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.eti.2024.103567","article-title":"Strategic enzymatic biodegradation of pharmaceutical pollutant carbamazepine by bacteria Rhodococcus zopfii","volume":"34","author":"Kasri","year":"2024","journal-title":"Environ Technol Innov"},{"key":"10.1016\/j.jhazmat.2026.143711_bib83","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00498258609043567","article-title":"The metabolism of 14 C-oxcarbazepine in man","volume":"16","author":"Sch\u00dctz","year":"1986","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jhazmat.2026.143711_bib84","unstructured":"Anzenbacherov\u00e1 E., Anzenbacher P., Svoboda Z., Ulrichov\u00e1 J., Kv\u011btina J., Zoulov\u00e1 J. , MODEL FOR DRUG METABOLISM IN MAN: COMPARISON OF IN VITRO AND IN VIVO METABOLISM OF PROPAFENONE. n.d."},{"key":"10.1016\/j.jhazmat.2026.143711_bib85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0378-4347(00)00292-9","article-title":"Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"748","author":"Hofmann","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.jhazmat.2026.143711_bib86","first-page":"408","volume":"26","author":"Biotransformation of Irbesartan in Man","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhazmat.2026.143711_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.139375","article-title":"Searching for pharmaceutically active products and metabolites in environmental waters of Peru by HRMS-based screening: Proposal for future monitoring and environmental risk assessment","volume":"337","author":"Fabregat-Safont","year":"2023","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib88","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhazmat.2026.143711_bib89","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.biopha.2015.01.022","article-title":"Tramadol hydrochloride: Pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems","volume":"70","author":"Vazzana","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jhazmat.2026.143711_bib90","unstructured":"FDA. PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION. n.d."},{"key":"10.1016\/j.jhazmat.2026.143711_bib91","unstructured":"Viewing Biotransformations for CN(C)CC1CCCCC1(C2=CC(=CC5C2)OC)O n.d. https:\/\/biotransformer.ca\/queries\/174046\/status?query_smiles= (accessed November 6, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib92","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.scitotenv.2019.06.118","article-title":"Aerobic biodegradation of tramadol by pre-adapted activated sludge culture: Cometabolic transformations and bacterial community changes during enrichment","volume":"687","author":"Kostanjevecki","year":"2019","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib93","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11356-011-0614-1","article-title":"Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants","volume":"19","author":"R\u00faa-G\u00f3mez","year":"2012","journal-title":"Environ Sci Pollut Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.174382","article-title":"Validation of LC-MS\/MS method for opioid monitoring in Valencia City wastewater: Assessment of synthetic wastewater as potential aid","volume":"946","author":"Sadutto","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2023.139094","article-title":"Basic micro-pollutants in sludge from municipal wastewater treatment plants in the Northwest Spain: Occurrence and risk assessment of sludge disposal","volume":"335","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2023","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib96","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0006-2952(99)00167-7","article-title":"Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways","volume":"58","author":"Bort","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib97","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/dmd.104.003095","article-title":"Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides","volume":"33","author":"Yan","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhazmat.2026.143711_bib98","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14656566.5.6.1347","article-title":"Aceclofenac in the management of inflammatory pain","volume":"5","author":"Legrand","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jhazmat.2026.143711_bib99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10295-004-0202-1","article-title":"Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli","volume":"32","author":"Vail","year":"2005","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.320","article-title":"A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers","volume":"17","author":"Rosenzweig","year":"2002","journal-title":"Human Psychopharmacol Clin Exp"},{"key":"10.1016\/j.jhazmat.2026.143711_bib101","unstructured":"[Amisulpride]Viewing Biotransformations for CCN1CCCC1CNC(=O)C2=CC(=C(C5C2OC)N)S(=O)(=O)CC n.d. https:\/\/biotransformer.ca\/queries\/178240\/status?query_smiles= (accessed November 7, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib102","unstructured":"[Sulpiride]Viewing Biotransformations for CCN1CCCC1CNC(=O)C2=C(C5CC(=C2)S(=O)(=O)N)OC n.d. https:\/\/biotransformer.ca\/queries\/174858\/status?query_smiles= (accessed November 7, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib103","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03189389","article-title":"Metabolism of sulpiride: determination of the chemical structure of its metabolites in rat, dog and man","volume":"3","author":"Sugnaux","year":"1978","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jhazmat.2026.143711_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.144677","article-title":"An integrated approach to MS-based identification and risk assessment of pharmaceutical biotransformation in wastewater","volume":"770","author":"Psoma","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.jhazmat.2026.143711_bib105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.chemosphere.2012.02.074","article-title":"Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions","volume":"88","author":"Gasser","year":"2012","journal-title":"Chemosphere"},{"key":"10.1016\/j.jhazmat.2026.143711_bib106","unstructured":"EU. COMMISSION IMPLEMENTING DECISION (EU) 2015\/ 495 - of 20 March 2015 - establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008\/ 105\/ EC of the European Parliament and of the Council - (notified under document C(2015) 1756). 2015."},{"key":"10.1016\/j.jhazmat.2026.143711_bib107","unstructured":"10-Methoxy Carbamazepine; Oxcarbazepine EP Impurity B n.d. https:\/\/synthinkchemicals.com\/product\/10-methoxy-carbamazepine-oxcarbazepine-ep-impurity-b\/#:\u223c:text=10,other%20names%20such%20as (accessed November 6, 2025)."},{"key":"10.1016\/j.jhazmat.2026.143711_bib108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psep.2018.05.004","article-title":"Carbamazepine degradation by UV and UV-assisted AOPs: kinetics, mechanism and toxicity investigations","volume":"117","author":"Ali","year":"2018","journal-title":"Process Saf Environ Prot"},{"key":"10.1016\/j.jhazmat.2026.143711_bib109","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cej.2018.10.125","article-title":"Modelling study on the effects of chloride on the degradation of bezafibrate and carbamazepine in sulfate radical-based advanced oxidation processes: Conversion of reactive radicals","volume":"358","author":"Wu","year":"2019","journal-title":"Chem Eng J"},{"key":"10.1016\/j.jhazmat.2026.143711_bib110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4314\/jfas.v9i6s.12","article-title":"Biodegradation of carbamazepine using fungi and bacteria","volume":"9","author":"Nasir","year":"2018","journal-title":"J Fundam Appl Sci"},{"key":"10.1016\/j.jhazmat.2026.143711_bib111","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1124\/dmd.119.089565","article-title":"Theophylline acetaldehyde as the initial product in doxophylline metabolism in human liver","volume":"48","author":"Zhao","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jhazmat.2026.143711_bib112","first-page":"3386","article-title":"Chemical Space covered by applicability domains of quantitative structure\u2013property relationships and semiempirical relationships in chemical assessments","volume":"58","author":"Zhang","year":"2024","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.jhazmat.2026.143711_bib113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3894(01)00207-2","article-title":"A review of structure-based biodegradation estimation methods","volume":"84","author":"Raymond","year":"2001","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jhazmat.2026.143711_bib114","unstructured":"Boehringer Ingelheim. Environmental risk assessment for Telmisartan. 2025."},{"key":"10.1016\/j.jhazmat.2026.143711_bib115","series-title":"UBA TEXTE 20\/2023 PMT\/vPvM assessment of REACH registered Substances Detected in Wastewater Treatment Plant Effluent","author":"Peter","year":"2023"},{"key":"10.1016\/j.jhazmat.2026.143711_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2024.122388","article-title":"Transformation products of diclofenac: Formation, occurrence, and toxicity implication in the aquatic environment","volume":"266","author":"Nosek","year":"2024","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.watres.2021.117052","article-title":"Occurrence of carbamazepine, diclofenac, and their related metabolites and transformation products in a French aquatic environment and preliminary risk assessment","volume":"196","author":"Zind","year":"2021","journal-title":"Water Res"},{"key":"10.1016\/j.jhazmat.2026.143711_bib118","doi-asserted-by":"crossref","unstructured":"Evaluation of the biological impact of the mixtures of diclofenac with its biodegradation metabolites 4\u2019-hydroxydiclofenac and 5-hydroxydiclofenac on Escherichia coli. DCF synergistic effect with caffeic acid. Archives of Environmental Protection 2023. https:\/\/doi.org\/10.24425\/aep.2020.135760.","DOI":"10.24425\/aep.2020.135760"},{"key":"10.1016\/j.jhazmat.2026.143711_bib119","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.envpol.2017.09.009","article-title":"Antimicrobial activity of pharmaceutical cocktails in sewage treatment plant effluent \u2013 An experimental and predictive approach to mixture risk assessment","volume":"231","author":"Menz","year":"2017","journal-title":"Environ Pollut"},{"key":"10.1016\/j.jhazmat.2026.143711_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.152485","article-title":"Environmental and human health risk assessment of mixture of Covid-19 treating pharmaceutical drugs in environmental waters","volume":"812","author":"Kumari","year":"2022","journal-title":"Sci Total Environ"}],"container-title":["Journal of Hazardous Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389426026920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304389426026920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:48:32Z","timestamp":1792957712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304389426026920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":120,"alternative-id":["S0304389426026920"],"URL":"https:\/\/doi.org\/10.1016\/j.jhazmat.2026.143711","relation":{},"ISSN":["0304-3894"],"issn-type":[{"value":"0304-3894","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Back-transformation and dual-type metabolites associated with pharmaceutical negative removal and residual ecological risks in biological treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Hazardous Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhazmat.2026.143711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"143711"}}